Let’s talk amylin: the next wave in metabolic and obesity care

Chair: W. Timothy Garvey (USA) 12:15 – 12:17 Welcome and introduction W. Timothy Garvey (USA) 12:17 – 12:38 Amylin in action: from mechanisms to meaningful outcomes  Akshay Jain (CAN)Liana Billings (USA)W. Timothy Garvey (USA) 12:38- 12:44 Audience Q&A W. Timothy Garvey (USA) 12:44 – 12:45 Summary and close W. Timothy Garvey (USA) Thursday, 01 October […]

Insulin efsitora alfa in type 2 diabetes: The evolution of basal insulin from daily to once-weekly formulations

Chair: Chantal Mathieu (BEL) 17:45 – 17:50 Welcome and introduction Chantal Mathieu (BEL) 17:50 – 18:00 From guideline recommendations to clinical reality: Barriers to achieving treatment targets with basal insulin in type 2 diabetes Athena Philis-Tsimikas (USA) 18:00 – 18:10 Insulin efsitora alfa in type 2 diabetes: Pharmacological properties for once weekly dosing Harpreet Bajaj […]

Advancing the amylin story: from scientific rationale to future cardiometabolic care

Chair: Carel Le Roux (IRL) 17:45 – 17:50 Opening perspectives: framing the amylin story Carel Le Roux (IRL) 17:50 – 18:05 Amylin biology in action: translating mechanism into clinical potential Thomas Lutz (CHE) 18:05 – 18:30 CagriSema in focus: connecting phase 3 evidence across obesity and T2D Arya Sharma (GER)Richard Pratley (USA) 18:30 – 18:40 […]

Liver-Directed Approach to Moderate to Advanced MASH: Implications for Diabetes Specialists

Chair: Gianluca Perseghin (ITA) 17:45 – 17:47 Welcome & Objectives Gianluca Perseghin (ITA) 17:47 – 17:57 MASH in Diabetes Care: Who to Treat, Why Now? Priya Jaisinghani (USA) 17:57 – 18:07 Managing MASH With Resmetirom, A Liver-Directed Treatment Massimo Levrero (FRA) 18:07 – 18:17 Addressing Liver Disease Beyond Glycemic and Weight Effects Sabine Kahl (DEU) […]

A New Direction in T1D? Redefining Success From Survival to Freedom

Chair: Lorenzo Piemonti (ITA) 16:00 – 16:02 Introduction  Lorenzo Piemonti (ITA) 16:02 – 16:07 Unmet needs and challenges for people living with T1D Lorenzo Piemonti (ITA) 16:07 – 16:12 Data gaps that persist in our understanding of T1D morbidity  Lorenzo Piemonti (ITA) 16:12 – 16:17 Redefining success  Lorenzo Piemonti (ITA) 16:17 – 16:22 Looking to […]

Early Intervention, Lasting Benefit: Reshaping the Obesity Treatment Paradigm

16:00 – 16:05 Opening — the unhealthy cost of waiting Arya Sharma (DEU) 16:05 – 16:10 Obesity as a chronic progressive disease Arya Sharma (DEU) 16:10 – 16:15 Obesity Related Complications (ORCs): which, when and why they converge  Luc Van Gaal (BEL) 16:15 – 16:23 Pharmacotherapy in the prevention & treatment of ORCs Luc Van […]